A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : LA / lactobionic acid

[Related PubMed/MEDLINE]
Total Number of Papers: 53
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   LA  (>> Co-occurring Abbreviation)
Long Form:   lactobionic acid
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Redox-responsive polyprodrug nanoparticles for targeted siRNA delivery and synergistic liver cancer therapy. ASGP, Bcl-2, HCPT, NPs
2019 A 10% Lactobionic acid-containing moisturizer reduces skin surface pH without irritation-An in vivo/in vitro study. AHAs, APGs, EI, SCH, TEWL
2019 A versatile strategy to create an active tumor-targeted chemo-photothermal therapy nanoplatform: A case of an IR-780 derivative co-assembled with camptothecin prodrug. CPT, NPs
2019 Dual-Targeted Lactoferrin Shell-Oily Core Nanocapsules for Synergistic Targeted/Herbal Therapy of Hepatocellular Carcinoma. DEN, GA, HCC, LF, NCs, QRC, SFB
2019 Engineered borate ester conjugated protein-polymer nanoconjugates for pH-responsive drug delivery. BSA, DOX, FA, PNIPAAm, PPNCs
2019 In situ synthesized lactobionic acid conjugated NMOFs, a smart material for imaging and targeted drug delivery in hepatocellular carcinoma. Al, DOX, NMOFs
2019 Lactic and lactobionic acids as typically moisturizing compounds. AHA and PHA, Lac
2019 Lactobionic Acid Conjugated Quercetin Loaded Organically Modified Silica Nanoparticles Mitigates Cyclophosphamide Induced Hepatocytotoxicity. CP
2019 Oxygenated theranostic nanoplatforms with intracellular agglomeration behavior for improving the treatment efficacy of hypoxic tumors. EP, PFC
10  2019 pH-sensitive doxorubicin-loaded polymeric nanocomplex based on beta-cyclodextrin for liver cancer-targeted therapy. DOX, HCC, SPCs, TSPCs
11  2019 Preparation of a one-dimensional nanorod/metal organic framework Janus nanoplatform via side-specific growth for synergistic cancer therapy. CT, DOX, JNPs, NIR, PAA
12  2019 Surface-modified PLGA nanoparticles with PEG/LA-chitosan for targeted delivery of arsenic trioxide for liver cancer treatment: Inhibition effects enhanced and side effects reduced. PEG, PLGA
13  2019 Synthesis and application of amino triazolium-modified lactobionic acid as chiral selector in capillary electrophoresis. CE
14  2019 Synthesis, application and molecular modeling study of ionic liquid functionalized lactobionic acid, 3-methyl-1-(3-sulfopropyl)-1H-imidazol-3-ium lactobionate, as a chiral selector in capillary electrophoresis. MSI-LA
15  2019 Tailored graphene oxide-doxorubicin nanovehicles via near-infrared dye-lactobionic acid conjugates for chemo-photothermal therapy. GO, GO/DOX
16  2018 A self-assembly nanodrug delivery system based on amphiphilic low generations of PAMAM dendrimers-ursolic acid conjugate modified by lactobionic acid for HCC targeting therapy. low-PAMAM, UA
17  2018 Acid-degradable lactobionic acid-modified soy protein nanogels crosslinked by ortho ester linkage for efficient antitumor in vivo. ASGPR, DOX
18  2018 Carrier-free nanodrug by co-assembly of chemotherapeutic agent and photosensitizer for cancer imaging and chemo-photo combination therapy. ASGPR, ICG, NDDS, NIR, NPs, PDT, PTT, ROS, UA
19  2018 Comparative evaluation of skin moisture after topical application of 10% and 30% lactobionic acid. ---
20  2018 Dual-targeted casein micelles as green nanomedicine for synergistic phytotherapy of hepatocellular carcinoma. BRB, CAS MCs, DSN, FA, HCC
21  2018 Experimental Evidence of the Healing Properties of Lactobionic Acid for Ocular Surface Disease. ELISA, HA, WH
22  2018 Lactobionic/Folate Dual-Targeted Amphiphilic Maltodextrin-Based Micelles for Targeted Codelivery of Sulfasalazine and Resveratrol to Hepatocellular Carcinoma. CMC, FA, MD, MDCA, RSV, SSZ, UDCA
23  2018 Targeted delivery of microRNA-199a-3p using self-assembled dipeptide nanoparticles efficiently reduces hepatocellular carcinoma in mice. HCC, miRNA, NPs
24  2018 The synthesis of LA-Fe3O4@PDA-PEG-DOX for photothermal therapy-chemotherapy. DOX, NIR
25  2017 Insight into the role of dual-ligand modification in low molecular weight heparin based nanocarrier for targeted delivery of doxorubicin. DOX, GA, HPC, LMWH, MDR
26  2017 Near-infrared light-mediated LA-UCNPs@SiO2-C/HA@mSiO2-DOX@NB nanocomposite for chemotherapy/PDT/PTT and imaging. C-dot, HA, NB linker, PDT, PTT, UC
27  2017 Simultaneous inhibition of growth and metastasis of hepatocellular carcinoma by co-delivery of ursolic acid and sorafenib using lactobionic acid modified and pH-sensitive chitosan-conjugated mesoporous silica nanocomplex. ASGPR, CS, HCC, MSN, SO, UA
28  2016 Alginate-based microcapsules with galactosylated chitosan internal for primary hepatocyte applications. AGCP, ASGPRs, CS, GC
29  2016 Fabrication of Biobased Polyelectrolyte Capsules and Their Application for Glucose-Triggered Insulin Delivery. CS, GC, LbL
30  2016 Galactosylated alginate-curcumin micelles for enhanced delivery of curcumin to hepatocytes. ALG, Alg-Cur, ASGPR
31  2016 Lactobionic acid and carboxymethyl chitosan functionalized graphene oxide nanocomposites as targeted anticancer drug delivery systems. CMC, DOX, GO
32  2016 Tailored Synthesis of Octopus-type Janus Nanoparticles for Synergistic Actively-Targeted and Chemo-Photothermal Therapy. JNPs, PEG
33  2016 Targeted delivery and controlled release of doxorubicin into cancer cells using a multifunctional graphene oxide. ASGPR, DOX, FI, PEG, PEI
34  2015 Cellular behaviour of hepatocyte-like cells from nude mouse bone marrow-derived mesenchymal stem cells on galactosylated poly(D,L-lactic-co-glycolic acid). AA, HLCs, ICP-CVD, MSCs, p-FAK, PAS, PLGA, RT-PCR
35  2015 Ligand-directed stearic acid grafted chitosan micelles to increase therapeutic efficacy in hepatic cancer. CS-SA, DOX
36  2014 Galactosylated poly(epsilon-caprolactone) membrane promoted liver-specific functions of HepG2 cells in vitro. GPCL, PCL
37  2014 Lactobionic acid-modified dendrimer-entrapped gold nanoparticles for targeted computed tomography imaging of human hepatocellular carcinoma. CT
38  2014 Lipid-AuNPs@PDA nanohybrid for MRI/CT imaging and photothermal therapy of hepatocellular carcinoma. ICG, MRI/CT
39  2014 Multifunctional lactobionic acid-modified dendrimers for targeted drug delivery to liver cancer cells: investigating the role played by PEG spacer. DOX, FI, PAMAM, PEG
40  2013 Hydrotropic polymeric mixed micelles based on functional hyperbranched polyglycerol copolymers as hepatoma-targeting drug delivery system. ASGP, NPs, PTX
41  2012 Design and synthesis of dual-ligand modified chitosan as a liver targeting vector. CTS, GA, IC50
42  2012 Lactobionic acid as antioxidant and moisturizing active in alkyl polyglucoside-based topical emulsions: the colloidal structure, stability and efficacy evaluation. APG
43  2011 Does lactobionic acid affect the colloidal structure and skin moisturizing potential of the alkyl polyglucoside-based emulsion systems? AHAs, APG
44  2011 Self-assembled virus-like particles from rotavirus structural protein VP6 for targeted drug delivery. DOX, DVP6, VLPs
45  2010 Galactosyl conjugated N-succinyl-chitosan-graft-polyethylenimine for targeting gene transfer. GPC, NSC-g-PEI, SEM
46  2010 Lactobionic acid in a natural alkylpolyglucoside-based vehicle: assessing safety and efficacy aspects in comparison to glycolic acid. AHAs, APG, GA, MI
47  2009 Immobilization of lactobionic acid on the surface of cadmium sulfide nanoparticles and their interaction with hepatocytes. CSNPs, LCSNPs, MCSNPs
48  2009 Self-assembly and characterization of Pluronic P105 micelles for liver-targeted delivery of silybin. TEM
49  2007 Identification of live liver cancer cells in a mixed cell system using galactose-conjugated fluorescent nanoparticles. GCFNPs
50  2007 Surface modification of magnetite nanoparticles using lactobionic acid and their interaction with hepatocytes. AAS, MA, MR
51  2005 Synergistic effect of poly(ethylenimine) on the transfection efficiency of galactosylated chitosan/DNA complexes. GC, PEI, WSC
52  2004 Galactosylated chitosan/DNA nanoparticles prepared using water-soluble chitosan as a gene carrier. ASGPR, GC, WSC
53  2003 Galactosylated low molecular weight chitosan as DNA carrier for hepatocyte-targeting. CaP, gal-LMWC, HeLa, HMWC, LMWC